BONDRONAT 2 mg, concentrate for solution for infusion bottle, 2 ml
Active ingredients: Ibandronic acid, Ibandronate sodium hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusionbottle, 2 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BONDRONAT 2 mg, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 2 ml
- Marketing authorisation holder
- ATNAHS PHARMA UK (ROYAUME-UNI)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jun 2005
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61213881CIP73656586CIP133400936565869Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IBANDRONIQUE (ACIDE)solution | 2 mg · un flacon | FT |
| IBANDRONIQUE (ACIDE), SEL MONOSODIQUE, MONOHYDRATÉsolution | 2,25 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.